Nicola Ammer

Title: Nicola Ammer: Innovator in Growth Hormone Assessment

Introduction

Nicola Ammer is a prominent inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of medical diagnostics, particularly in assessing growth hormone deficiency in children and humans. With a total of 2 patents, her work has the potential to impact the way growth hormone deficiencies are diagnosed and treated.

Latest Patents

Nicola Ammer's latest patents include innovative methods for measuring growth hormone levels. One patent focuses on the use of macimorelin in assessing growth hormone deficiency in children. This invention provides a method for measuring growth hormone levels in a human child, including a stand-alone test for assessing pituitary-related growth hormone deficiency. The method involves the oral administration of an effective amount of macimorelin, followed by the collection of blood samples to determine growth hormone levels. The second patent outlines a method for assessing growth hormone deficiency in humans and animals using a macimorelin-containing composition, further enhancing diagnostic capabilities.

Career Highlights

Throughout her career, Nicola has worked with notable companies such as Aeterna Zentaris GmbH and Æterna Zentaris GmbH. Her experience in these organizations has contributed to her expertise in the field of growth hormone research and diagnostics.

Collaborations

Nicola has collaborated with esteemed colleagues, including Gilbert Muller and Richard Sachse. These partnerships have fostered innovation and advancement in her research endeavors.

Conclusion

Nicola Ammer's contributions to the field of growth hormone assessment demonstrate her commitment to improving medical diagnostics. Her innovative patents and collaborations highlight her role as a leading inventor in this important area of healthcare.